Lariatin A

Lariatins is a novel anti-mycobacterial peptides with a lasso structure produced by Rhodococcus jostii K01-B0171[1].

Product Specifications

CAS Number

[732286-09-8]

UNSPSC

12352209

Target

Bacterial

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/lariatin-a.html

Solubility

10 mM in DMSO

Smiles

O=C([C@H]1NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC(CC1)=O)=O)CO)=O)CCC(N)=O)=O)CC(C)C)=O)C(C)C)=O)CC2=CC=C(C=C2)O)=O)CCCNC(N)=N)=O)N[C@H](C(N[C@@H](C(C)C)C(NCC(N[C@H](C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N3[C@@H](CCC3)C(O)=O)=O)=O)=O)=O)=O)=O)CC4=CN=CN4)=O)=O)=O)CC5=CNC6=CC=CC=C56

Molecular Formula

C94H143N27O25

Molecular Weight

2051.31

References & Citations

[1]Iwatsuki M, et al. Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171. J Antibiot (Tokyo) . 2007;60 (6) :357-363.